GILD logo

Gilead Sciences (GILD) Current Liabilities

Annual Current Liabilities

$11.28 B
+$42.00 M+0.37%

December 31, 2023


Summary


Performance

GILD Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGILDbalance sheetmetrics:

Quarterly Current Liabilities

$11.72 B
+$944.00 M+8.76%

September 30, 2024


Summary


Performance

GILD Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGILDbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

GILD Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.4%+3.9%
3 y3 years-1.0%+3.9%
5 y5 years+6.4%+3.9%

GILD Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2.8%+0.4%-16.0%+37.0%
5 y5-year-2.8%+15.6%-16.0%+37.0%
alltimeall time-3.0%>+9999.0%-16.0%>+9999.0%

Gilead Sciences Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$11.72 B(+8.8%)
Jun 2024
-
$10.78 B(-17.2%)
Mar 2024
-
$13.02 B(+15.4%)
Dec 2023
$11.28 B(+0.4%)
$11.28 B(-5.6%)
Sep 2023
-
$11.95 B(-14.5%)
Jun 2023
-
$13.96 B(+32.6%)
Mar 2023
-
$10.53 B(-6.3%)
Dec 2022
$11.24 B(-3.2%)
$11.24 B(+7.8%)
Sep 2022
-
$10.42 B(+13.0%)
Jun 2022
-
$9.22 B(+7.7%)
Mar 2022
-
$8.56 B(-26.3%)
Dec 2021
$11.61 B(+1.9%)
$11.61 B(+13.3%)
Sep 2021
-
$10.24 B(+0.3%)
Jun 2021
-
$10.21 B(+5.2%)
Mar 2021
-
$9.71 B(-14.8%)
Dec 2020
$11.40 B(+16.8%)
$11.40 B(+19.9%)
Sep 2020
-
$9.51 B(-10.0%)
Jun 2020
-
$10.56 B(+19.0%)
Mar 2020
-
$8.88 B(-9.0%)
Dec 2019
$9.76 B(-8.0%)
$9.76 B(+2.0%)
Sep 2019
-
$9.57 B(+6.8%)
Jun 2019
-
$8.96 B(-4.6%)
Mar 2019
-
$9.40 B(-11.4%)
Dec 2018
$10.61 B(-8.9%)
$10.61 B(+4.8%)
Sep 2018
-
$10.12 B(-7.3%)
Jun 2018
-
$10.91 B(+2.3%)
Mar 2018
-
$10.67 B(-8.3%)
Dec 2017
$11.63 B(+26.2%)
$11.63 B(+21.2%)
Sep 2017
-
$9.60 B(+13.0%)
Jun 2017
-
$8.49 B(+2.5%)
Mar 2017
-
$8.28 B(-10.2%)
Dec 2016
$9.22 B(-6.8%)
$9.22 B(-16.8%)
Sep 2016
-
$11.07 B(+6.0%)
Jun 2016
-
$10.44 B(-4.3%)
Mar 2016
-
$10.91 B(+10.3%)
Dec 2015
$9.89 B(+71.7%)
$9.89 B(+5.7%)
Sep 2015
-
$9.36 B(+4.9%)
Jun 2015
-
$8.93 B(+20.2%)
Mar 2015
-
$7.43 B(+28.9%)
Dec 2014
$5.76 B(-10.1%)
$5.76 B(-4.9%)
Sep 2014
-
$6.05 B(-2.8%)
Jun 2014
-
$6.23 B(+5.3%)
Mar 2014
-
$5.91 B(-7.7%)
Dec 2013
$6.41 B(+51.2%)
$6.41 B(+30.9%)
Sep 2013
-
$4.90 B(-0.9%)
Jun 2013
-
$4.94 B(+15.1%)
Mar 2013
-
$4.29 B(+1.2%)
Dec 2012
$4.24 B(+68.5%)
$4.24 B(-11.7%)
Sep 2012
-
$4.80 B(-3.7%)
Jun 2012
-
$4.99 B(+19.1%)
Mar 2012
-
$4.19 B(+66.5%)
Dec 2011
$2.51 B(+2.0%)
$2.51 B(+13.1%)
Sep 2011
-
$2.22 B(-3.7%)
Jun 2011
-
$2.31 B(-16.5%)
Mar 2011
-
$2.77 B(+12.3%)
Dec 2010
$2.46 B(+31.7%)
$2.46 B(-4.8%)
Sep 2010
-
$2.59 B(-16.6%)
Jun 2010
-
$3.11 B(+64.5%)
Mar 2010
-
$1.89 B(+0.9%)
Dec 2009
$1.87 B(+53.3%)
$1.87 B(-0.9%)
Sep 2009
-
$1.89 B(+6.3%)
Jun 2009
-
$1.78 B(+40.9%)
Mar 2009
-
$1.26 B(+3.3%)
Dec 2008
$1.22 B
$1.22 B(-3.0%)
Sep 2008
-
$1.26 B(-48.6%)
Jun 2008
-
$2.45 B(+161.1%)
DateAnnualQuarterly
Mar 2008
-
$939.00 M(+27.5%)
Dec 2007
$736.27 M(-3.7%)
$736.27 M(+6.5%)
Sep 2007
-
$691.44 M(-8.0%)
Jun 2007
-
$751.73 M(+5.8%)
Mar 2007
-
$710.49 M(-7.0%)
Dec 2006
$764.28 M(+64.3%)
$764.28 M(+31.4%)
Sep 2006
-
$581.83 M(+14.5%)
Jun 2006
-
$507.97 M(+20.4%)
Mar 2006
-
$421.90 M(-9.3%)
Dec 2005
$465.16 M(+83.5%)
$465.16 M(+73.7%)
Sep 2005
-
$267.87 M(+2.6%)
Jun 2005
-
$261.19 M(-3.3%)
Mar 2005
-
$270.22 M(+6.6%)
Dec 2004
$253.45 M(+36.3%)
$253.45 M(+16.5%)
Sep 2004
-
$217.53 M(+24.4%)
Jun 2004
-
$174.83 M(-0.5%)
Mar 2004
-
$175.79 M(-5.4%)
Dec 2003
$185.90 M(+77.2%)
$185.90 M(+39.3%)
Sep 2003
-
$133.40 M(-2.3%)
Jun 2003
-
$136.59 M(+5.1%)
Mar 2003
-
$130.01 M(+23.9%)
Dec 2002
$104.89 M(+30.9%)
$104.89 M(+22.7%)
Sep 2002
-
$85.48 M(+3.4%)
Jun 2002
-
$82.69 M(+19.7%)
Mar 2002
-
$69.08 M(-13.8%)
Dec 2001
$80.12 M(+37.6%)
$80.12 M(+11.7%)
Sep 2001
-
$71.74 M(+26.6%)
Jun 2001
-
$56.69 M(+2.7%)
Mar 2001
-
$55.20 M(-5.2%)
Dec 2000
$58.24 M(+21.6%)
$58.24 M(+15.0%)
Sep 2000
-
$50.63 M(+13.4%)
Jun 2000
-
$44.63 M(+4.6%)
Mar 2000
-
$42.67 M(-10.9%)
Dec 1999
$47.88 M(-16.4%)
$47.88 M(-15.7%)
Sep 1999
-
$56.80 M(+110.4%)
Jun 1999
-
$27.00 M(-7.8%)
Mar 1999
-
$29.30 M(-48.9%)
Dec 1998
$57.30 M(+71.6%)
$57.30 M(+83.1%)
Sep 1998
-
$31.30 M(-1.9%)
Jun 1998
-
$31.90 M(-13.6%)
Mar 1998
-
$36.90 M(+10.5%)
Dec 1997
$33.40 M(+107.5%)
$33.40 M(+60.6%)
Sep 1997
-
$20.80 M(-3.3%)
Jun 1997
-
$21.50 M(-13.7%)
Mar 1997
-
$24.90 M(+54.7%)
Dec 1996
$16.10 M(+37.6%)
$16.10 M(0.0%)
Sep 1996
-
$16.10 M(+10.3%)
Jun 1996
-
$14.60 M(-2.7%)
Mar 1996
-
$15.00 M(+36.4%)
Dec 1995
$11.70 M(+7.3%)
-
Sep 1995
-
$11.00 M(+14.6%)
Jun 1995
-
$9.60 M(-11.9%)
Mar 1995
-
$10.90 M(+4.8%)
Mar 1995
$10.90 M(+23.9%)
-
Dec 1994
-
$10.40 M(-2.8%)
Sep 1994
-
$10.70 M(+33.8%)
Jun 1994
-
$8.00 M(-9.1%)
Mar 1994
$8.80 M(+39.7%)
$8.80 M(+12.8%)
Dec 1993
-
$7.80 M(-4.9%)
Sep 1993
-
$8.20 M(+64.0%)
Jun 1993
-
$5.00 M(-20.6%)
Mar 1993
$6.30 M(+162.5%)
$6.30 M(+26.0%)
Dec 1992
-
$5.00 M(+11.1%)
Sep 1992
-
$4.50 M(+150.0%)
Jun 1992
-
$1.80 M(-25.0%)
Mar 1992
$2.40 M(+33.3%)
$2.40 M(+33.3%)
Mar 1991
$1.80 M
$1.80 M

FAQ

  • What is Gilead Sciences annual total current liabilities?
  • What is the all time high annual current liabilities for Gilead Sciences?
  • What is Gilead Sciences annual current liabilities year-on-year change?
  • What is Gilead Sciences quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Gilead Sciences?
  • What is Gilead Sciences quarterly current liabilities year-on-year change?

What is Gilead Sciences annual total current liabilities?

The current annual current liabilities of GILD is $11.28 B

What is the all time high annual current liabilities for Gilead Sciences?

Gilead Sciences all-time high annual total current liabilities is $11.63 B

What is Gilead Sciences annual current liabilities year-on-year change?

Over the past year, GILD annual total current liabilities has changed by +$42.00 M (+0.37%)

What is Gilead Sciences quarterly total current liabilities?

The current quarterly current liabilities of GILD is $11.72 B

What is the all time high quarterly current liabilities for Gilead Sciences?

Gilead Sciences all-time high quarterly total current liabilities is $13.96 B

What is Gilead Sciences quarterly current liabilities year-on-year change?

Over the past year, GILD quarterly total current liabilities has changed by +$444.00 M (+3.94%)